Comparison of serum antibody titer of 8 types of commercial live infectious bronchitis vaccine in broiler chickens

Subject Areas : Veterinary Clinical Pathology

saman  mahdavi ¹ (استادیار گروه میکروبیولوژی، واحد مراغه، دانشگاه آزاد اسلامی، مراغه، ایران.)
afshin  zakeri ² (استادیار گروه علوم دامی، واحد تبریز، دانشگاه آزاد اسلامی، تبریز، ایران.)
yuosef  Mehmannavaz ³ (استادیار گروه علوم دامی، واحد مراغه، دانشگاه آزاد اسلامی، مراغه، ایران.)

Received: 2014-06-17 Accepted : 2014-08-27 Published : 2014-08-23

Keywords: broiler chicken, Infectious Bronchitis, Live vaccine, Serum antibody,

Abstract :

The aim of this study was to compare the serum antibody titer of 8 types of commercial live infectious bronchitis vaccines in broiler chickens. Three hundred and twenty one-day-old male broiler chickens (308 Ross strain) were divided into 8 groups (each group comprised of 3 replicates) randomly. At 8 days of age, each treatment group received different types of live infectious bronchitis vaccine by eye-drop method. Twelve birds from each group were randomly chosen and blood sample was taken on the 22nd and 29th days of experimental period and ELISA test was performed on sera for detection of sample antibody titer. The mean of serum antibody titer against infectious bronchitis vaccines among treatment groups on the 22nd day of experimental period showed statistical significance between the group that had received HIPRAVIAR Colon/ H120 and the groups that had received Nobilis Ma5+ Clone30, H120 and Cevac Vitabron L (p<0.05) but no statistical significance was seen between the other treatment groups. The mean of serum antibody titer against infectious bronchitis vaccines among treatment groups on the 29th day of experimental period showed no statistical significance between the treatment groups. The comparison of serum antibody titer against infectious bronchitis vaccines in treatment groups between the 22nd and 29th day of experimental period showed statistical significance between the groups that had received Gallivax IB88, Nobilis Ma5+Clone30 and Cevac Vitabron L (p<0.05) but there were no statistical significance between the other treatment groups. 

References:

• غلامی آهنگران، م. (1392). سنجش ایمونوگلوبولین A در مخاطات دستگاه تنفس به دنبال تجویز واکسن برونشیت عفونی در جوجه‌های گوشتی. نشریه میکروبیولوژی دامپزشکی، دوره 9، شماره 1، صفحات: 49-41.
  
  
  
  • · Calnek, B.W., John Barnes, H., Beard, C.W., Mc Dougald, L.R. and Saif, Y.M. (1997). Diseases of Poultry. Iowa, USA: Iowa State University Press, pp: 519.
  
  
  • · Cavanagh, D. (2003). Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology, 32(6): 567-582.
  
  
  • · Gelb, J., Nix, W.A. and Gellman, S.D. (1998). Infectious bronchitis virus antibodies in tears and their relationship to immunity. Avian Diseases, 42: 364-374.
  
  
  • · Gillete, K.G. (1980). Local antibody response in avian infectious bronchitis: virus-neutralizing antibody in tracheobronchial secretions. Avian Diseases, 25: 431-443.
  
  
  • · Guo, X., Rosa, A.J.M., Chen, D.G. and Wang X. (2008). Molecular mechanisms of primary and secondary mucosal immunity using avian infectious bronchitis virus as a model system. Veterinary Immunology and Immunopathology, 121: 332-343.
  
  
  • · Hay green, L., Davison, F. and Kaiser, P. (2005). DNA vaccines for poultry: the jump from theory to practice. Expert Review of Vaccines, 4(1): 51-62.
  
  
  • · Ignjatovic, J. and Galli, L. (1994). The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens. Archives of Virology, 138: 117-134.
  
  
  • · Johnson, M.A., Pooley, C., Ignjatovic, J. and Tyack, S.G. (2003). A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis. Vaccine, 22: 2730-2736.
  
  
  • · Marius, V., Gillet, J.P., Hospitalier, R.L., Guittet, M. and Bennejean, G. (1983). Vaccination against Infectious Bronchitis in young chicken. Comparative Immunology Microbiology Infectious Diseases, 6(2): 115-134.  
  
  
  • · Mondal, S.P. and Naqi, S.A. (2001). Maternal antibody to infectious bronchitis virus: It’s role in protection against infection and development of active immunity to vaccine. Veterinary Immunology and Immunopathology, 79(1-2): 31-40.
  
  
  • · Saif, Y.M., Barnes, H.J., Glisson, J.R., Fadly, A.M., Mc Dougald, L.R. and Swayne, D.E. (2003).  Diseases of poultry. 11th ed., Iowa, USA: Iowa State University Press, pp: 101-119.
  
  
  • · Statistical Analysis System (2004). SAS Institute, Cary, NC, USA.
  
  
  • · Van Ginkel, F.W., Van Santen, S.L., Gulley, S.L. and Toro, H. (2008). Infectious bronchitis virus in the chicken harderian gland and lachrimal fluid: viral load, infectivity, immune cell responses, and effects of viral immunodeficiency. Avian Diseases, (52): 608-617.
  
  
  • · Zakeri, A. and Kashefi, P. (2011). A comparative study of immunization of 5 various commercial Infectious Bronchitis live vaccines in broiler chickens. Advances in Environmental Biology, 5(8): 2532-2535.
  
  
  • · Zinkernagel, R.M. (2003). On natural and artificial vaccinations. Annual Review of Immunology, 21: 516-546.